Acellular pertussis vaccines for use among infants and young children

Author： Campins-Martí Magda   Moraga-Llop Fernando A  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.5, Iss.4, 2004-04, pp. : 807-817

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HIV Vaccines in Infants and Children

By Lambert John S.  

Pediatric Drugs, Vol. 7, Iss. 5, 2005-01 ,pp. : 267-276

Adis International

Access to resources Recommend Favorite

Acellular Pertussis Vaccine Safety and Efficacy in Children, Adolescents and Adults

By Casey Janet R.   Pichichero Michael E.  

Drugs, Vol. 65, Iss. 10, 2005-01 ,pp. : 1367-1389

Adis International

Access to resources Recommend Favorite

Advances in Pneumococcal Vaccines: Advantages for Infants and Children

By Jolanta Bernatoniene   Adam Finn  

Drugs, Vol. 65, Iss. 2, 2005-01 ,pp. : 229-255

Adis International

Access to resources Recommend Favorite

Diphtheria-Tetanus-Acellular Pertussis Vaccine Adsorbed (Triacelluvax™; DTaP3-CB): A Review of its Use in the Prevention of Bordetella pertussis Infection

By Matheson A.J.   Goa K.L.  

Pediatric Drugs, Vol. 2, Iss. 2, 2000-03 ,pp. : 139-159

Adis International

Access to resources Recommend Favorite

Economic Evaluation of a New Acellular Vaccine for Pertussis in Canada

By Iskedjian M.   Einarson T.R.  

PharmacoEconomics, Vol. 19, Iss. 5, 2001-01 ,pp. : 551-563

Adis International

Access to resources Recommend Favorite